0.018
0.00 (-10.00%)
| Previous Close | 0.020 |
| Volume | 5,035,041 |
| Price / Sales | 121.56 |
| Price / Book | 5.53 |
| 52 Weeks Range |
| Operating Margin (TTM) | -70.59% |
| Diluted EPS (TTM) | 0.000 |
| Quarterly Revenue Growth (YOY) | -24.20% |
| Total Debt/Equity (MRQ) | 29.44% |
| Current Ratio (MRQ) | 5.28 |
| Operating Cash Flow (TTM) | -6.32 M |
| Levered Free Cash Flow (TTM) | -3.71 M |
| Return on Assets (TTM) | -57.94% |
| Return on Equity (TTM) | -140.07% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Specialty Chemicals (AU) | Mixed | Mixed |
| Specialty Chemicals (Global) | Mixed | Bullish | |
| Stock | ANTEO TECH FPO [ADO] | - | - |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | 1.0 |
| Average | 0.50 |
|
AnteoTech Ltd is a biotechnology company engaged in the development of specialty products and services and end-user diagnostic products focused on the Battery and Life Science diagnostics markets. Its key areas are the Energy and Life Science Division. The company is developing four products named AnteoX, Ultranode, AnteoBind NXT, and AnteoBind these products are used in the energy, diagnostic, and medical device markets. The company currently has a single segment which is the development of the AnteoTech IP. |
|
| Sector | Basic Materials |
| Industry | Specialty Chemicals |
| Investment Style | Small Value |
| % Held by Insiders | 16.00% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |